over the news gilly in astrazeneca looking to -- gilead and astrazeneca looking to combine.y have made an offer for gilead which is also working on a treatment. joining us is nancy tengler of tengler your thoughts on this possible tie up? you, and congrats on the new show. concept, -- the m&a concept but the market is starting to pay attention to normal things and ceos are considering how to rationalize businesses for the future. historically these mergers are good for the sector. this would make sense on the face of it. i think there are big hurdles in and cross pondcs politics if you will. like the fact that the ceos work together and the product type lines are complementary, but i think it is early days and the stocks are not necessarily reflecting that the market thinks this is going to happen in the near term. nancy, let's talk more broadly about the market. you talk about the fact that you could see this as a sign of things getting back to normal. don'tmarkets in some way feel normal and are responding to huge liquidity from central banks and not looking at the economi

i would argue that astrazeneca needs this more.ith gilead walked into a situation where prior management fumbled the football with response to building the pipeline. in the event of gilead chair for would be required. our target as a standalone company is $90, which some investors would argue would be optimistic. i think there could be significant support for gilead shareholders for maximum potential for value creation in the event of a merger. what is gilead worth if we get a vaccine? how much is remdesivir baked into the price? how much of the price is around remdesivir? if we would see demand falling because there was an effective vaccine, would that change the arithmetic? tyler: good question. , i thinkof the base most would argue gilead is worth about $70 per share, may high 60's. probably five dollars of that is remdesivir. in an optimistic scenario, depending on if you're willing to ascribe multibillion revenues , maybe if you get into the mid-80's or $90 per share. i do not think there is a ton of value in the stock from re

astrazeneca much better than gilead.d doing some catch up on the possibility of its virus drug. that could be one reason astrazeneca is interested. could be because they have a bigger r&d pipeline, one of the biggest out there. very attractive to astrazeneca. vonnie: thanks, abigail. new york city is officially entered its first phase of reopening today. a small but important step toward normality. starts tolth crisis ease, and mental health crisis is unfolding across the u.s. amid social protest and unrest. laura murphy is a senior clinical psychologist with the johns hopkins business school of public health. what are your primary concerns right now that given cities are reopening and people have been inside for a long time, those that observed total lockdown. : i think we have a lot of different concerns from the mental health perspective. stress is real for everyone. it comes in different forms, dynamics, uncertainties about the virus, recent uncertainty about jobs and schooling, the of the virus,y changes to relation

if you think about it from astrazeneca's perspective, it does need growth. it has that in spades when you look at it compared to its peers. be ayou -- it could quicker solution to alleviating cash flow. -- cash flow issues. he has been trying to fund r&d. for itsas the potential all-time share price to go and acquire and merge with a company that gives it potentially the largest r&d budget out there. idea that the astrazeneca is a unique invention of its own, but is it growth for growth's sake? it is not so much a financial raison d'etre, but is there a reason for this merger given the entire global industry? sam: i actually don't think they need to buy growth. they certainly will not be buying growth if they merge with gilead. iliad is a slower growth story. they will get the potential to spending $9 billion a year to $10 billion a year on r&d as a combined group. that would be second only to roche. if you are very good at doing r&d come as astrazeneca has shown us recently, maybe it is better -- if you are very good at doing r&d, as astrazeneca has shown u

astrazeneca is the u.k.'biggest drugmaker in his valued 0 billion and one of the codevelopers of a vaccine for coronavirus. meanwhile gilead its u.s. rival is valued at $96 billion as of friday. so the combination of these two 240panies would be almost $ billion. gilead is the maker of the only u.s. approved treatment remdesivir. bloomberg news has learned astrazeneca made up preliminary and in formal approach to gilead about a potential merger of months ago. according to people close to the matter, that contact was made to gauge gilead's interest in a possible tie up. most people say that no terms were specified. while gilead has discussed the idea with advisors, no decisions have been made. this is according to people close to the matter. representatives for both companies declined to comment. astrazeneca has made treatments for conditions ranging from crazed -- cancer to cardiovascular disease. there are analysts who question the therapeutic synergy but the financials make sense. astrazeneca stock has been

acceptable in the united states is astrazeneca?ems to be becoming increasingly embedded in the response to covid-19. sam: that is an interesting angle i had not thought about. , they are of the day a company that currently sells a similar type of product for an infectious disease. it is used for the treatment of respiratory virus. it is an antibody. it is an area they know, and they obviously have partnered with a well-known u.s. facility. maybe it does help them. i never really wondered what the political angle of astrazeneca-gilead would be. i cannot see why that would be an issue when it ends up being a merger of two companies with little overlap. not a lot of costs 20 required -- not a lot of cost-cutting required, either. to piggyback off of that. raising the profile in the u.s. for astrazeneca. works, i cannot imagine the u.s. than being ok with astrazeneca giving this antibody first to the u.k. or another country. sam: remember, that is a very good point. with these antibodies, you are not looking at giving it to everybody u

astrazeneca falling after bloomberg carried our story that astrazeneca had contacted gilead.ach. and in the aviation industry, the iag gaining. ahead with pressing a two-week quarantine on international arrivals. of us get more details on the story. the move has come under fire. they say it will devastate towards him in the country. along with threatening to sue the government, this has been raised in conversations with the unions. joining us is our reporter. so angeredthat ba, by the quarantine roles, is threatening to sue the government and they are not alone about this. with ryanair and other travel companies in the u.k. are considering suing the government over the policy saying it was curtailing coronavirus while also destroying thousands of jobs. the feeling among airlines and other travel companies is that most airlines are restarting their flights in the middle the month or early next month, there is still a worry that this might put off people from booking travel later in the summer which is crucial for airlines. would notfinitely want to fly to london if i knew i wa

i don't think anybody wanted astrazeneca to do a deal of this size. i don't know if there will be a bid for gilead. story in anyowth way, at least from what sources are expecting. this is like the opposite, from a position of strength to buy longer-term stability to invest in r&d. we have any indication this will go ahead? it is a matter of when? sam: i don't think they are any regulatory issues here. unless governments and politics get in the way which i don't see why that would be the case, we won't see a deal of that synergy , about having more firepower. it might cut a little bit of overlap, but not much. aside from that, i don't see what the risks would be and is gilead really interested? who knows? the report comes from a good bunch of analysts and news reporters who i am assuming have some good sources. francine: sam, thank you so much . coming up, after america's jobs reports, americans are looking for reassurance from jay powell. we discussed the rate decision next. -- we discuss the rate decision next. this is bloomberg. ♪ francine: economic

and astrazeneca is said to have made a preliminary approach to gilead. a merger between the two would be the biggest deal ever in the sector. it has just gone see it -- 6:00 a.m. in london. nejra, welcome back. you went away and you unleashed the burn. i know you are excited. curvee never far from a steepener. bondthis momentum in the market be a repricing or is there a risk from jay powell to the bond market? a few bonds at 1%. the older you get, the more enticing 1% looks. good morning. bears were really on a tear. curve is the steepest in more than three years. it is good to be back. last week was a memorable week. was it really a turning point for risk assets? that is the question. how high will the hurdles be this week? the ecb went above and beyond last week. can we expect much from the fed this week? futures are positive in the u.s. european futures are looking a little negative. eighth day ofits declines. a lot of that has to do with the euro strength. we have pulled back from the 2008 low. it broke out of the twentysomething basis point range. a

is it possible, certainly, that the ceo of astrazeneca brought up the idea?ps in terms of their product portfolios but the overriding theme in pharma which is if you are looking to sustain your business, you still need to spend a lot on rnd and a bigger revenue line allows you to spend more on the rnd line, jim. doesn't mean that these kinds of things aren't going away as an idea it does appear perhaps trying to figure something out for astrazeneca which has figured over the last few years prominently in a lot of different, at least rumors but, again, i think i can tell you safely here. there's nothing going on between these two companies at present >> well, because gilead, obviously, has developed remdesivir and part of the cocktail but more importantly astrazeneca teamed up with the university of oxford and talking about 2 billion doses of a vaccine to be ready at the end of the year. why the heck would they need gilead astrazeneca is on the way up and gilead is questionable and it's questionable because they're not out to try to make a lot of money on this

astrazeneca is said to be interested in a merger with gilead.formal contact has been made in what would be the biggest health care deal in history. no terms have been released endo decisions have been taken. astrazeneca is valued at $140 billion, with gilead with just under $100 billion. we are told gilead is not interested in a sale or merger. apple inc. to boost sales by letting people pay by a monthly installment. the plan will be pulled out in the coming months by the apple card, letting customers split the cost of new gadgets with interest-free payments. the deal would cover ipads, keyboards, and some monitors. apple launched a program last year with 24 months at zero interest. -- netease would raise rent doing to 70 billion u.s. dollars when it begins trading on you say -- on tuesday -- itld raise $200 billion when begins trading on tuesday. billion whene $270 it begins trading on tuesday. >> we are taking a look at stocks, u.s. futures pointing higher by 0.7%. nikkei futures getting more than 1%. again holding steady after a three day dec

astrazeneca has yet to determine whether the vaccine will work, but is preparing for mass production.>> meanwhile, the leader of the world health organization has urged countries not to lower their guard. he said there were 136,000 cases reported worldwide on sunday, the largest number in a single day. >> the situation in europe is improving. globally it's worsening. more than 100,000 cases have been reported on nine of the past ten days, almost 75% of yesterday's cases come from ten cocountries, m mostly in the americas and south asia. >> johns hopkins university in the united states says the total number of cases worldwide has topped 7.1 million. the global death toll is over 400,000. >>> north korea says it's shutting down hotlines with south korea. pyongyangg say it's the fst step i cuttingng all mmunication with seoul, describingtsts southern neighbor as an enemy.y. the setback in relations comes after defefectors set leaflets into the north that criticized kim jojong-un. they say leaflet campaign was a hostile act and considers south core covid-19 officials of trying to dodge re

far-xi-ga astrazeneca may be able to help.t or one that's good for my teeth? now i don't have to choose. crest 3d white. it removes up to 95% of surface stains. and strengthens enamel. from the number one toothpaste brand in america. crest. and assemble more vehicles here than anyone else. it's why at moment's notice we can take american ingenuity and put it to work. building respirators, ventilators and face shields. building what we've been building for over a century. an unbreakable connection between the ford motor company and america. >>> here, we promised to stay on the images. they're just as important. tonight, so many of you at home reacting to the story from last night. the peaceful protesters welcomed by the officers. ngice chief, steve mylett, and a demonstrator embracing. in miami, you see the line of law enforcement, and the moment it all changes. a highway patrol trooper walking up to this woman and hugging her. she was grateful. in times square, all the sudden in the middle of a protest, an officer kneeling, ra

if you can't afford... ...your medication, astrazeneca may be able to help.-xi-ga astrazeneca may be able to help. when your v-neck looks more like a u-neck... that's when you know, it's hby conditioning fibers,preventg so clothes look newer, longer. downy and it's done. i come face to face with a lot of behinds. so i know there's a big need for gas-x maximum strength. it works fast. relieving pressure, bloating, and discomfort before you know it. so no one needs to know you've got gas. so to help even more, geico is giving new and current customers a fifteen percent credit on their motorcycle policies with the geico giveback. and because we're committed for the long haul, the credit lasts your full policy term. the geico giveback. helping riders focus on the road ahead. the geico giveback. (vo) imagine a visibly healthier purina one.ays. natural ingredients... in powerful combinations. for radiant coats, sparkling eyes. purina one. one visibly healthy pet. also, see what our protein-rich wet food can do. reopening, but the financial fallout from the pandemic

if you can't afford... ...your medication, astrazeneca may be able to help.astrazeneca may be able to help. we do things differently and aother money managers, don't understand why. because our way works great for us! but not for your clients. that's why we're a fiduciary, obligated to put clients first. so, what do you provide? cookie cutter portfolios? nope. we tailor portfolios to our client's needs. but you do sell investments that earn you high commissions, right? we don't have those. so, what's in it for you? our fees are structured so we do better when our clients do better. at fisher investments we're clearly different. unlike ordinary wmemory supplementsr? neuriva has clinically proven ingredients that fuel 5 indicators of brain performance. memory, focus, accuracy, learning, and concentration. try neuriva for 30 days and see the difference. than rheumatoid arthritis or psoriatic arthritis. when considering another treatment, ask about xeljanz xr, a once-daily pill for adults with moderate to severe rheumatoid arthritis or active psoriatic arthritis

far-xi-ga astrazeneca may be able to help.ou have nausea, ♪upset stomach, diarrheaon,♪ pepto bismol coats and soothes your stomach for fast relief and now, get the same fast relief in a delightful chew with new pepto bismol chews. sprinting past every leak in our softest, smoothest fabric. she's confident, protected, her strength respected. depend. the only thing stronger than us, is you. than rheumatoid arthritis or psoriatic arthritis. when considering another treatment, ask about xeljanz xr, a once-daily pill for adults with moderate to severe rheumatoid arthritis or active psoriatic arthritis for whom methotrexate did not work well enough. it can reduce pain, swelling, and significantly improve physical function. xeljanz can lower your ability to fight infections like tb; don't start xeljanz if you have an infection. taking a higher than recommended dose of xeljanz for ra can increase risk of death. serious, sometimes fatal infections, cancers including lymphoma, and blood clots have happened. as have tears in the stomach

trials will begin for us on the ninth of july with moderna followed by astrazeneca and jensen. sen. gillibrand: thank you, mr. chairman. [no audio] sen. inhofe: senator cotton? [no audio] >> senator kotten you are not muted -- can cotton: general perna, you hear me? gen. perna: i can. sen. cotton: i would like to talk about the balance you tend to -- you intend to strike between a safe and effective fda approved vaccine on the one hand but also getting that vaccine as quickly as possible out to our citizens. could you speak to that issue a bit? gen. perna: first of all i am remarkably proud of our scientists and researchers in health and human services and the department of defense. be the on them to medical experts and i rely on them heavily in the recommendations and advice to ensure that we are executing all medical protocols appropriately and that we will hold ourselves accountable to that end. simultaneously, while all of those are going on recommendations accordingly from the chief medical advisor and the other scientists and researchers have allowed us to assess the capabilit

revising merger monday, the potential pairing between gilead sciences and astrazeneca. that and so much more coming up. romaine: a health pandemic, recession, and of course those protests over the police killing of george floyd have transformed the landscape in the u.s.. we want to welcome james knightley, the ing chief economist recently published a u.s. election scenario. time seven months ago, we had an economy that was at a very minimum, stable, the incumbent president had the advantage of having a good economy, low employment -- low unemployment, and a lot of things at his back. is there any real sense that will hold that against him in october? james: nothing really sticks right now. i think when you look at the economic performance, you can certainly look at the equity market. 11% year onis up year. presssaw in the conference on friday, saying the covid-19 situation is happening but i am getting unemployment down. my economic policies are working clearly, he is trying to move on to the front foot. the george floyd situation does create a really challenging situat

astrazeneca,nson, merck, and also pfizer. they are the ones.panies, johnson & astrazeneca,k, they are giants in the pharmaceutical world. madera is a small company -- moderna is a small company, only 10 years old. how did you get here so quickly? stephane: we have a platform. a moleculeis we use --ween dna in your cells what we can do is we can basically use instructions. these enable us to do actually nine vaccines in the clinic before this one. this is why we are going to grow so fast. startedhe company was , you werego originally recruited to go on -- one year later, they made you the ceo. was that your plan? stephane: i was at the time running a public company, a global leader in diagnostics for infectious disease. i was before at eli lilly. of moderna was the founder and ceo of flagship ventures. he approached me and was like, come on the board and help us out. as i got to see the company and know the technology, i began to believe that it was possible that this company could be a big disruption to the entire pharmaceutical industry. ceo a

government has already pledged up to $1.2 billion to astrazeneca to make the university of oxford vaccineme of the most high-profile candidates but there are more than 130 vaccines currently under development. david: more than 130 under development. but when we spoke to the inovio ceo of, they had one of the candidates that was furthest along, along with astrazeneca and others. is the defense department onlyng money into inovio or are they interested in others? kailey: we have seen a lot of grants coming from the hhs department that this is a big priority for the u.s. government. we heard dr. anthony fauci testifying on capitol hill today saying the vaccine is critical to overcoming this virus. he says it is a matter of when, not if we get a vaccine, and expects to have one by the end of the year. but it takes a lot of funding to make that happen by the end of the year, as well as the scale that we need to see us get out of the other side. david: an interesting fact about inovio, the gates foundation has also given them some funding. they have some nonprofit supporters as well. it appears

astrazeneca says it will be able to deliver 2 billion doses of its potential coronavirus vaccine when and if that comes to pass for low and middle income countries thanks to two g ates-backed global health organizations, it's about up half a percent, astrazeneca less than a tenth of a percent really but its had a very good move over the past couple of weeks. also, the gates foundation novav ax is getting funding from the u.s. department of defense for its vaccine candidate and it's up 2.75%. so we've been talking about how areas of the country are reopening. the first theme park to reopen in florida is comcast-owned universal orlando resort it is now open to the public with capacity limits and social distancing protocols that stock is up 2.25% to $42 and change. we got to talk about the lucky number 13. usually it's not lucky, well it's lucky now. a whole host of companies are hitting a 13-week high, in fact they are vaulting over three-month highs athletic wear maker nike that one is moving it's up about 2%, food products giant kraft heinz is up 3% flip it over to medtech company str

astrazeneca. this is interesting. we talk about covid all the time this is one of the names that's out there that a lot of folks are leaning on and wondering about. we have had activity in the past now, today we had even more. astrazeneca, we had buyer of 65 calls. 13,000 for about 60 cents. that was the stock trading a little higher than it is right now. keep an eye on both of those, scott. >> let's talk shares of nike sinking today. the disappointing results. with us today the number one analyst on wall street matt boss, jpmorgan. matt, welcome back >> thanks for having me on >> one of the analysts, including you, i hate to say, get it so wrong? >> we called for a miss into the quarter. we felt fourth quarter consensus was too high and the first quarter the front half of the year, the wholesale exposure this company has was larger than people -- larger than people were modeling in terms of just the risk with the ex assess inventories out there. what came in worse is leverage or lack throfereof. you were closed eight

if you can't afford your medication, astrazeneca may be able to help. of new gain with essential oilsergent.t she was really feeling it when... she remembered everything. you've got this girl. just inhale. and repeat. new gain with essential oils detergent. i was told to begin my aspirin regimen, blem. and i just didn't listen. until i almost lost my life. my doctors again ordered me to take aspirin, and i do. be sure to talk to your doctor before you begin an aspirin regimen. listen to the doctor. take it seriously. puts cash back in your wallet. earn 5% cash back on everything you buy at walmart.com... mom! paper towels! ...including things for the science fair. to have constipation with belly pain, straining, and bloating, again and again. no way. more exercise. more water. and more fiber is the only way to manage it. is it? maybe you think... it's occasional constipation. maybe it's not. it could be a chronic medical condition called ibs-c, and time to say yesss! to linzess. linzess works differently than laxatives. it helps relieve belly pain and lets you have more frequent and c

the chief executive of pharmaceutical giant astrazeneca told the bbc has company had already startedoeuver the oxford university covid-19 vaccine. if i passes human trials, it could be made available in october.yo re watching bbc world news america. still to come on tonight's program, echoes of past upheavals with the race riots of the early 10's in america can tell us about what's happening today.[m ♪ic] >> the e.u. cef negotiator has criticized the lack of progrs toward post-brexit trade talks. he accused the u.k. of backtracking on key commitments in the political declaration.br hiish counterpart acknowledged there had been only limited process. re's more. reporter: there have been four rounds of negotiations so far,si e the u.k. had left the e.u. and there's been no progress at all on the key sticking points between the two sides. so that's over e.u. rights, to fish in u.k. waters. it's also on so-called level playing field conditions. that's basically the e.u. saying there has to be fair competiti between the two sides, after exit, so competition, regulations. also how the whole

it's competing with big companies like pfizer and astrazeneca.e don't know how it's going to shake out. but we have seen some pretty good results in animal testing. they are doing a special type of vaccine called an mra vaccccine. it is supposed t to be much similar -- simpler to create. it's s one of the reasons why it is seen as a good investment for the german government right now. brent: we've got about 30 seconds. this is the company that donald trump reportedly tried to buy earlier this year. why are these vaccines suddenly becoming so political? chesea: you have to consider that it comes in the backdrop of huge tensions between the u.s., europe, china, there's so much nationalism going on an economic policy in general and politics in general. that's one of the bigger pressures but it also has highlighted the concern that once a vaccine is found, that it won't be distributed in it democratic way. countries like the u.s. and germany that had the funding to invest will have first access, and it's going to be every man for himself. brent: chel

call or go online today. >>> "good morning america" is sponsored by astrazeneca. morning i'm rentggie. we hope to learn today more about the plans to reopen the schools. they'll unveil guidelines for classrooms going forward. physical distancing is one of the major issues he's expected to address, also face coverings for students and teachers. let's turn to mike nicco with a look at our monday. hi, mike. >> hi, everybody. let's look at what's going to happen today. it will be breezy this afternoon, nothing like the weekend, a little warmer as up60 l 7s, mid toer . 70s around the bay, low to mid 80s inland. my forecast, warm tuesday and wednesday day, but not as warm as the last couple mini heat waves. coolest on friday. >>> coming up on gma, some tips on how to get online and get your wifi kicked into high speed. another update coming up in about 30 minutes. we'll see you then. ♪ ♪ we've always put safety first. ♪ ♪ and we always will. ♪ ♪ for people. ♪ ♪ for the future. and there has never been a summer when it's mattered more. wherever you go, summer safely. get

astrazeneca stands with you. for the support you need and the care you deserve. still be closed, but our hearts are open. doobegins with ingredients from the earthn... to create fragrances infused with natural essential oils. air wick scented oils. connect to nature. my haircolor was less vibrant. i had to rescue it. olia. haircolor powered by 60% oils, no ammonia. the color is really rich. it looks healthier than before i colored it. my hair's happy right now. olia. by garnier, naturally. and beverages that are very acidic. it can soften the enamel. pronamel repair, what it's doing is driving more minerals deep into the enamel surface, that's going to help actively repair. pronamel is taking it to another level. that's going to help actively repair. a lot of folks ask me why their dishwasher doesn't get everything clean. i tell them, it may be your detergent... that's why more dishwasher brands recommend cascade platinum... ...with the soaking, scrubbing and rinsing built right in. for sparkling-clean dishes, the first time. cascade platinum. saturpain happens.

if you can't afford... ...your medication, astrazeneca may be able to help.-xi-ga when this crisis is don'going to be overp. and we don't know exactly when the stock market will reach its bottom, we've got to be prepared for this to last a long time. if you assume that you're out of work for nine months but you end up only being out of work for... r ck pain? before i take anything, i apply topical pain relievers first. salonpas lidocaine patch blocks pain receptors for effective, non-addictive relief. salonpas lidocaine. patch, roll-on or cream. hisamitsu. so here's to the strong, who trust in our performance and comfortable, long-lasting protection. because your strength is supported by ours. depend. the only thing stronger than us, is you. an extra 15 percent credit on car and motorcycle policies? ok? that's 15 percent on top of what geico could already save you. so what are you waiting for? dj khaled to be your motivational coach? yo devin! remember to brush in a circle motion. thank you... dj... khaled. tiny circles, devin. do another one. another one. is

industry heavy weights are behind some of the front-runners, pfizer, johnson & johnson, merck, astrazenecancouraging news about a potential coronavirus vaccines, with the drug-maker moderna, that showed promising stages. >> reporter: moderna touted promising early results for its vaccine, which uses an unconventional new approach to creating immunity. >> we are desperate for a vaccine. as a consequence, we're looking for any sort of news that could be good. but i think what we should exercise here is humility. >> reporter: dr. paul offit is a member of the national institutes of health panel, overseeing the accelerated development of a covid vaccine. he fears what he calls an october surprise, and co-authored this op-ed in the "new york times." >> i worry as we move to september, october, and election day, that will will be a pressure to get a vaccine out there, even if it hasn't been tested in the way it needs to be tested. >> reporter: what that means is giving a vaccine to at least 20,000 people, with another 10,000 getting a placebo. and then waiting to see who gets a disease and who d

astrazeneca stands with you. for the support you need and the care you deserve. doors may still be closed, but our hearts are open. capital one knows life doesn't update you about your credit card. so meet eno...the capital one assistant that looks out for charges that might surprise you and helps you fix them. what's in your wallet? >>> we're back with a new warning about protesters testing positive for coronavirus and what the case numbers could look like weeks after this massive worldwide s.emonstrations. >> reporter: a warning tonight for protests and social gathering by their very nature are at odds, a perfect recipe for spreading the virus. >> but it's a delicate balance because the reasons for demonstrating are valid and yet the demonstration itself puts one at an additional risk. >> reporter: and now his words being realized. in columbus, ohio, health officials announcing a protester had covid-19 and was symptomatic during a rally. in athens georgia the commissioner tested positive and warned fellow demonstrators in a facebook post if you spoke on sunday

bloomberg reported that uk astrazeneca approached gilead for some sort of merger or deal. important? astrazeneca is working on a coronavirus vaccine and gilead makes the treatment for coronavirus remdesivir. are they talking? reports say they are not. citi analysts do say a merger is very unlikely and the reason being that both governments would have to green light a merger. citi doesn't think that's possible. nonetheless stocks are moving on this report. now astrazeneca since it is more unlikely they do do this deal with gilead, that stock is down 3.25% right now, ashley. ashley: lauren, thank you very much. from drugmakers to pizza makers, an iconic new york city peas rea says enough is enough, plans to reopen today. susan. susan: he is not supposed to. this is iconic pizzeria in new york on six of this avenue. it was part of damage and looting that took place last week. grimaldi's saying enough is enough. you can only open in phase two. then only curbside pickup. grimaldi's being institution in new york says we want to get back to normal. they are opening today defying

you heard from pascal from astrazeneca earlier.ou think there is only one app in development? do you know what? it strange, isn't it? we have a centralised nhs system when we have opted for a central app with a central database. in opted for a central app with a central data base. in my opted for a central app with a central database. in my opinion, we should have gone on multiple tracks. like i said, there are 123 vaccines in development, and the government is paying for the imperial college and the oxford vaccines, so why not play multiple horses in the race for the best track and trace app? so we have the best tools available to test, track and trace. we have testing going on now. very good. now we need to do the tracking, and uses many digital technologies as we can. we are on standby to help. thank you for explaining that. you know there is an ethical debate, which you have touched on, around patient data, and there is a view of this information belongs to the patient and not the state, and i suppose perhaps there is the poten

four european countries have signed a deal with the pharmaceutical giant astrazeneca, in the hope oft coronavirus from the end of the year. the deal is the first signed by an alliance of germany, france, italy and the netherlands, to secure doses for all eu member states. the prime minister of italy says it should turn the coronavirus crisis into an opportunity to push through long—delayed reforms. among the plans announced by giuseppe conte are for the country to simplify bureaucracy, improve education and support the poorest. italy is set to be the largest beneficiary of a huge eu recovery fund. russia has reported more than 8,000 new coronavirus cases on saturday, raising its total to over 520,000. it means russia has the third—highest number in the world after the united states and brazil. its official death toll stands at 6,829, many times lower than the figure seen in other countries with serious outbreaks. canadians have been reacting to disturbing footage which has emerged, showing police punching and applying a chokehold on an indigenous chief in alberta. it's prompted the p

if you can't afford... ...your medication, astrazeneca may be able to help. when this crisis is don'going to be overp. and we don't know exactly when the stock market will t of work nine mthsm, youume ate and we don't know exactly when so here's to the strong, who trust in our performance and comfortable, long-lasting protection. because your strength is supported by ours. depend. the only thing stronger than us, is you. you're not welcome here! get out of my face! hpv can cause certain cancers when your child grows up. get in its way. hpv can affect males and females... and there's no way to predict who will or won't clear the virus. but you can help protect your child by taking a first step. thremmds hpvr won't vaccinn 1 2e virus. to help protect against certain cancers. hey cancer! not... my... child. don't wait... >> o'donnell: tonight, >> o'donnell: tonight, microsoft is joining amazon and i.b.m. in refusing to sell its facial recognition software to police until the controversial tracking technology is regulated. the tech giants are among a growing numb

astrazeneca stands with you. for the support you need and the care you deserve.rs may still be closed, but our hearts are open. doors moves like these need ♪born to be wild pampers cruisers 360° fit with an ultra-stretchy waistband and 360° fit that adapts to every wild move plus up to 12 hours of pampers protection so anything your wild child does cruisers can too our best ever fit is pampers cruisers 360° fit neuriva has clinically proven oingredients that fuel five, indicators of brain performanc: memory, focus, accuracy, learning, and concentration. try our new gummies for 30 days and see the difference. home instead has helped seniors stay home. now, staying home isn't just staying in the place they love. it's staying safe. home instead. to us, it's personal. it's staying safe. a lot of folks ask me why their dishwasher doesn't get everything clean. i tell them, it may be your detergent... that's why more dishwasher brands recommend cascade platinum... ...with the soaking, scrubbing and rinsing built right in. for sparkling-clean dishes, the first time. casc

astrazeneca stands with you. for the support you need and the care you deserve.ll be closed, but our hearts are open. to sleepy smudges... to shower-skipping. these days call for a quick clean. luckily, help is still one wipe away. love, neutrogena®. ...little things... ...can become your big moment. that's why there's otezla. otezla is not a cream. it's a pill that treats plaque psoriasis differently. with otezla, 75% clearer skin is achievable. don't use if you're allergic to otezla. it may cause severe diarrhea, nausea or vomiting. otezla is associated with an increased risk of depression. tell your doctor if you have a history of depression or suicidal thoughts or if these feelings develop. some people taking otezla reported weight loss. your doctor should monitor your weight and may stop treatment. upper respiratory tract infection and headache may occur. tell your doctor about your medicines, and if you're pregnant or planning to be. otezla. show more of you. and geico loves helping riders get to where they're going, so to help even more, geico is giving ne

if you can't afford... ...your medication, astrazeneca may be able to help.-ga puts cash back in your wallet. earn 5% cash back on everything you buy at walmart.com... mom! paper towels! ...including things for the science fair. what's in your wallet? saturpain happens. aleve it. aleve is proven stronger and longer on pain than tylenol. when pain happens, aleve it. all day strong. (vo) imagine a visibly healthier purina one.ays. natural ingredients... in powerful combinations. for radiant coats, sparkling eyes. purina one. one visibly healthy pet. also, see what our protein-rich wet food can do. frto baking fails...inters... sessions. things like sweat and oil. but it's nothing a deep clean can't fix. love, neutrogena®. to have constipation with belly pain, straining, and bloating, again and again. no way. more exercise. more water. and more fiber is the only way to manage it. is it? maybe you think... it's occasional constipation. maybe it's not. it could be a chronic medical condition called ibs-c, and time to say yesss! to linzess. linzess works differentl

if you can't afford your medication, astrazeneca may be able to help. sometimes, you can find yourself heading in a new direction. but when you're with fidelity, a partner who makes sure every step is clear, there's nothing to stop you from moving forward. sprinting past every leak in our softest, smoothest fabric. she's confident, protected, her strength respected. depend. the only thing stronger than us, is you. theand we want to thank times, the extraordinary people she's confident, protected, her strength respected. in the healthcare community, working to care for all of us. at novartis, we promise to do our part. as always, we're doing everything we can to help keep cosentyx accessible and affordable. if you have any questions at all, call us, email us, visit us online. we're here to help support you when you need us. take care, and be well. to learn more, call one eight four four cosentyx or visit cosentyx.com the wind in your hair... the feeling of freedom that drives us to go out and discover.. at chevy, we're committed to getting you there with